Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Lotus Pharmaceutical Co., Ltd. (1795) Stock Price & Analysis

1795 Stock Chart & Stats

NT$166.00-NT$2.00(-1.19%)
At close: 12:30 AM EST
TWD 160TWD 170TWD 180TWD 190Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 154.00 - TWD 166.00
52-Week Range
TWD 154.00 - TWD 364.76
Previous Close
TWD 168.00
Volume
N/A
Average Volume (3M)
951.34K
Market Cap
TWD 44.15B
Enterprise Value
TWD 102.18B
Total Cash (Recent Filing)
TWD 6.33B
Total Debt (Recent Filing)
TWD 58.45B
Price to Earnings (P/E)
11.5
Beta
0.43
Next Earnings
Mar 18, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Aug 31, 2026
Dividend Yield
1.55%

Bulls Say, Bears Say

Bulls Say

Multi-year Revenue Growth

Revenue nearly doubled across 2020-2025, demonstrating sustained commercial expansion rather than dependence on a single reporting period. This trajectory supports broader market reach, greater operating scale, and a stronger base for continued product development and commercialization.

Healthy Profitability

Despite recent pressure, Lotus continues to generate sector-healthy profitability, indicating that its generic and complex-generic portfolio retains meaningful economic value. Durable margins can help fund regulatory filings, product development, manufacturing, and distribution across target markets.

Positive Operating Cash Flow

Positive and rising operating cash flow shows that the business continues to convert its operations into internally generated funds. That cash provides an important foundation for ongoing investment, debt servicing, and commercial execution even as conversion efficiency has weakened.

Bears Say

Sharp Leverage Increase

The sharp increase in leverage materially changes Lotus's financial risk profile from its previously conservative position. Higher debt can increase interest burden and reduce flexibility to invest, absorb weaker operating results, or manage future financing needs over the next several quarters.

Margin Compression

The broad decline in gross and net margins indicates that higher revenue is currently producing less profit per unit of sales. If sustained, this compression could limit earnings growth, reduce reinvestment capacity, and signal continuing cost pressure or an unfavorable product mix.

Weaker Cash Conversion

Lower cash conversion means reported earnings are translating less effectively into operating and free cash flow. Combined with a roughly 33% decline in free cash flow, this may constrain internally funded growth and make the recently higher debt burden more consequential.

1795 FAQ

What was Lotus Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Lotus Pharmaceutical Co., Ltd. lowest stock price was TWD 154.00 and its highest was TWD 364.76 in the past 12 months.
What is Lotus Pharmaceutical Co., Ltd.’s market cap?
Lotus Pharmaceutical Co., Ltd.’s market cap is TWD 44.15B.
When is Lotus Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Lotus Pharmaceutical Co., Ltd.’s next earnings report is estimated for Nov 05, 2026 (not yet confirmed), which is 5 days ago.
How were Lotus Pharmaceutical Co., Ltd.’s earnings last quarter?
Lotus Pharmaceutical Co., Ltd. released its earnings results on Aug 13, 2026. The company reported TWD 2.409 earnings per share for the quarter, missing the consensus estimate of TWD 3.409 by -TWD 1.
Is Lotus Pharmaceutical Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Lotus Pharmaceutical Co., Ltd. pay dividends?
Lotus Pharmaceutical Co., Ltd. pays a ― dividend of TWD 2.565 which represents an annual dividend yield of 1.55%. See more information on Lotus Pharmaceutical Co., Ltd. dividends here
What is Lotus Pharmaceutical Co., Ltd.’s EPS estimate?
Lotus Pharmaceutical Co., Ltd.’s EPS estimate is 4.13.
How many shares outstanding does Lotus Pharmaceutical Co., Ltd. have?
Lotus Pharmaceutical Co., Ltd. has 270,035,250 shares outstanding.
What happened to Lotus Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Lotus Pharmaceutical Co., Ltd. reported an EPS of TWD 2.409 in its last earnings report, missing expectations of TWD 3.409. Following the earnings report the stock price went up 5.66%.
Which hedge fund is a major shareholder of Lotus Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in TW:1795
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology